Unichem Labs gets USFDA nod to market Allopurinol tablets Farhat Nasim15 March 2019 9:35 AM ISTAllopurinol tablets will be commercialised from company's Ghaziabad plant, Unichem Laboratories said.New Delhi: Drug firm Unichem Laboratories...
Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan Farhat Nasim13 March 2019 1:49 PM ISTValsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney...
Lupin, Natco receives USFDA nod for Imatinib Mesylate tablets Farhat Nasim6 March 2019 9:30 AM ISTImatinib Mesylate is a generic version of Novartis Pharmaceuticals Corporation's Gleevec tablets in the same strengths, Lupin said in a filing to BSE....
Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer Farhat Nasim27 Feb 2019 9:30 AM ISTThe company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
Novartis Kymriah wins UK backing after initial lymphoma snub Medical Dialogues Bureau3 Feb 2019 10:00 AM IST"Today's positive announcement regarding access to Kymriah treatment in England and Wales was secured as a result of our close working collaboration...
Cancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby Powder Medical Dialogues Bureau1 Feb 2019 12:51 PM ISTCOLOMBO (Reuters) - Sri Lanka has halted imports of Johnson & Johnson Baby Powder until the company proves its product is free from cancer-causing...
U.S. senator asks J&J for documents on talc, baby powder safety Medical Dialogues Bureau30 Jan 2019 9:15 AM ISTThe letter addressed to J&J Chief Executive Alex Gorsky asks for documents and information related to testing of its talc products for the...
Bayer asks judge to limit evidence in another round up cancer trial Medical Dialogues Bureau24 Jan 2019 9:15 AM ISTBayer denies allegations that glyphosate causes cancer, saying decades of independent studies have shown the world's most widely-used weed killer to...
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal Farhat Nasim9 Jan 2019 9:15 AM ISTSanofi will pay Regeneron $462 million representing the balance of payments due under their original deal, which covers the Sanofi share of the...
Abbvie to record $4 billion impairment charges on Stemcentrx assets Medical Dialogues Bureau6 Jan 2019 9:00 AM ISTThe drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
Johnson & Johnson talc issue: NGO writes to National Human Rights Commission Medical Dialogues Bureau25 Dec 2018 9:35 AM ISTThe NGO has said that it has sought to draw the "urgent attention" of the rights panel, towards the relevance of the report on the baby talc powder...
Bayer reduces combined sales estimate for its experimental drugs Medical Dialogues Bureau8 Dec 2018 9:20 AM ISTFRANKFURT: Germany's Bayer, which acquired seed company, Monsanto, this year, reduced its combined sales estimate for its most promising experimental...
